Literature DB >> 26497963

The coiled-coil domain of MURC/cavin-4 is involved in membrane trafficking of caveolin-3 in cardiomyocytes.

Daisuke Naito1, Takehiro Ogata1, Tetsuro Hamaoka1, Naohiko Nakanishi1, Kotaro Miyagawa1, Naoki Maruyama1, Takeru Kasahara1, Takuya Taniguchi1, Masahiro Nishi1, Satoaki Matoba1, Tomomi Ueyama2.   

Abstract

Muscle-restricted coiled-coil protein (MURC), also referred to as cavin-4, is a member of the cavin family that works cooperatively with caveolins in caveola formation and function. Cavins are cytoplasmic proteins with coiled-coil domains and form heteromeric complexes, which are recruited to caveolae in cells expressing caveolins. Among caveolins, caveolin-3 (Cav3) is exclusively expressed in muscle cells, similar to MURC/cavin-4. In the heart, Cav3 overexpression contributes to cardiac protection, and its deficiency leads to progressive cardiomyopathy. Mutations in the MURC/cavin-4 gene have been identified in patients with dilated cardiomyopathy. In the present study, we show the role of MURC/cavin-4 as a caveolar component in the heart. In H9c2 cells, MURC/cavin-4 was localized at the plasma membrane, whereas a MURC/cavin-4 mutant lacking the coiled-coil domain (ΔCC) was primarily localized to the cytoplasm. ΔCC bound to Cav3 and impaired membrane localization of Cav3 in cardiomyocytes. Additionally, although ΔCC did not alter Cav3 mRNA expression, ΔCC decreased the Cav3 protein level. MURC/cavin-4 and ΔCC similarly induced cardiomyocyte hypertrophy; however, ΔCC showed higher hypertrophy-related fetal gene expression than MURC/cavin-4. ΔCC induced ERK activation in cardiomyocytes. Transgenic mice expressing ΔCC in the heart (ΔCC-Tg mice) showed impaired cardiac function accompanied by cardiomyocyte hypertrophy and marked interstitial fibrosis. Hearts from ΔCC-Tg mice showed a reduction of the Cav3 protein level and activation of ERK. These results suggest that MURC/cavin-4 requires its coiled-coil domain to target the plasma membrane and to stabilize Cav3 at the plasma membrane of cardiomyocytes and that MURC/cavin-4 functions as a crucial caveolar component to regulate cardiac function.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  cardiac hypertrophy; caveolae; heart failure; membrane structure; muscle-restricted coiled-coil protein

Mesh:

Substances:

Year:  2015        PMID: 26497963     DOI: 10.1152/ajpheart.00446.2015

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  Analysis of selected genes associated with cardiomyopathy by next-generation sequencing.

Authors:  Viktoria Szabadosova; Iveta Boronova; Peter Ferenc; Iveta Tothova; Jarmila Bernasovska; Michaela Zigova; Jan Kmec; Ivan Bernasovsky
Journal:  J Clin Lab Anal       Date:  2017-06-08       Impact factor: 2.352

Review 2.  Caveolins and cavins in the trafficking, maturation, and degradation of caveolae: implications for cell physiology.

Authors:  Anna R Busija; Hemal H Patel; Paul A Insel
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-25       Impact factor: 4.249

3.  Effect of atorvastatin on cardiomyocyte hypertrophy through suppressing MURC induced by volume overload and cyclic stretch.

Authors:  Wen-Pin Cheng; Huey-Ming Lo; Bao-Wei Wang; Su-Kiat Chua; Kou-Gi Shyu
Journal:  J Cell Mol Med       Date:  2018-12-03       Impact factor: 5.310

4.  Systems Network Genomic Analysis Reveals Cardioprotective Effect of MURC/Cavin-4 Deletion Against Ischemia/Reperfusion Injury.

Authors:  Masahiro Nishi; Takehiro Ogata; Carlo Vittorio Cannistraci; Sara Ciucci; Naohiko Nakanishi; Yusuke Higuchi; Akira Sakamoto; Yumika Tsuji; Katsura Mizushima; Satoaki Matoba
Journal:  J Am Heart Assoc       Date:  2019-07-31       Impact factor: 5.501

5.  Dietary α-Linolenic Acid Counters Cardioprotective Dysfunction in Diabetic Mice: Unconventional PUFA Protection.

Authors:  Jake S Russell; Tia A Griffith; Saba Naghipour; Jelena Vider; Eugene F Du Toit; Hemal H Patel; Jason N Peart; John P Headrick
Journal:  Nutrients       Date:  2020-09-02       Impact factor: 5.717

6.  Cytoskeletal disorganization underlies PABPN1-mediated myogenic disability.

Authors:  Cyriel Sebastiaan Olie; Erik van der Wal; Domagoj Cikes; Loes Maton; Jessica C de Greef; I-Hsuan Lin; Yi-Fan Chen; Elsayad Kareem; Josef M Penninger; Benedikt M Kessler; Vered Raz
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

7.  Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults.

Authors:  Divyanshu Dubey; Grayson Beecher; M Bakri Hammami; Andrew M Knight; Teerin Liewluck; James Triplett; Abhigyan Datta; Surendra Dasari; Youwen Zhang; Matthew M Roforth; Calvin R Jerde; Stephen J Murphy; William J Litchy; Anthony Amato; Vanda A Lennon; Andrew McKeon; John R Mills; Sean J Pittock; Margherita Milone
Journal:  JAMA Neurol       Date:  2022-08-01       Impact factor: 29.907

8.  MURC deficiency in smooth muscle attenuates pulmonary hypertension.

Authors:  Naohiko Nakanishi; Takehiro Ogata; Daisuke Naito; Kotaro Miyagawa; Takuya Taniguchi; Tetsuro Hamaoka; Naoki Maruyama; Takeru Kasahara; Masahiro Nishi; Satoaki Matoba; Tomomi Ueyama
Journal:  Nat Commun       Date:  2016-08-22       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.